IP Library Patent Application 13303580
Patent Application
App. No. 13/303,580

NOVEL COMPLEXES OF FATTY ACID ESTERS OF POLYHYDROXYALKANES AND PYRIDINE CARBOXY DERIVATIVES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/303,580
Abstract

The present invention relates to novel combinations of fatty acid derivatives and pyridine carboxy derivatives, including fatty acid esters with glycerol and 3-carboxy pyridine derivates such as niacinamide. Such combinations have surprisingly shown antiviral and anti-microbial activity and the use for the treatment of inflammatory conditions and infections is disclosed herein.

Claims (14)

1 - 62 . (canceled)

63 . A method for the treatment of a disease associated with hypersensitivity and/or inflammatory reactions, said method comprising the administration of

i) glyceryl monocaprylate or an alkali metal salt thereof and

ii) niacinamide or a salt thereof,

wherein said disease is selected from the group consisting of hypersensitivity skin disease, pruritus, urticaria, atopic eczema, contact dermatitis, seborrhoeic dermatitis, acne, rosacea, alopecia, vitiligo, and psoriasis.

64 . The method according to claim 63 , wherein said disease is seborrhoeic dermatitis.

65 . The method according to claim 63 , wherein the component (i) is racemic, enantiomerically enriched or enantiomerically pure 1-glyceryl-monocaprylate.

66 . The method according to claim 63 , wherein the component (ii) is niacinamide.

67 . The method according to claim 63 , wherein said combination further comprises one or more therapeutically active agents.

68 . The method according to claim 63 , wherein the combination is formulated for oral, topical, transdermal, or parenteral administration.

69 . The method according to claim 68 , wherein the combination is formulated for topical administration.

70 . The method according to claim 63 , wherein the component (i) and the component (ii) are present in a molar ratio of between about 1:3 to 1:16.

71 . The method according to claim 70 , wherein the component (i) and the component (ii) are present in a molar ratio of about 1:14 or about 2:7.

72 . The method according to claim 65 , wherein the component (ii) is niacinamide.

Assignments (2)
ASSET PURCHASE AGREEMENT Recorded Jul 11, 2016
From: ASTION PHARMA A/S
To: CIPHER PHARMACEUTICALS INC.
Reel/Frame 039301/0307 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2012
From: WEIDNER, MORTEN SLOTH
To: ASTION DERMATOLOGY A/S
Reel/Frame 027710/0877 →